Determining the feline immunodeficiency virus (FIV) status of FIV-vaccinated cats using point-of-care antibody kits

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 42, Issue , 2015, Pages 43-52

  Westman, Mark E ^a   Malik, Richard ^a   Hall, Evelyn ^a   Sheehy, Paul A ^a   Norris, Jacqueline M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cats; ELISA; Feline immunodeficiency virus; FIV diagnosis; FIV vaccination; Immunochromatography; PCR; Serology

Indexed keywords

ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; AUSTRALIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEASIBILITY STUDY; FELINE IMMUNODEFICIENCY VIRUS; FEMALE; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOASSAY; LATERAL FLOW ELISA TEST KIT; LATERAL FLOW IMMUNOCHROMATOGRAPHY TEST KIT; LENTIVIRUS INFECTION; MALE; NONHUMAN; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION SYSTEM; SENSITIVITY AND SPECIFICITY; VACCINATION; ANIMAL; BLOOD; CAT; COMPARATIVE STUDY; DIAGNOSTIC KIT; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; IMMUNOLOGY; POINT OF CARE SYSTEM; SEROLOGY; VETERINARY;

DIAGNOSTIC KIT; FELINE LEUKEMIA VIRUS VACCINE; ONCOPROTEIN; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMALS; ANTIBODIES, VIRAL; AUSTRALIA; CATS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; IMMUNOCHROMATOGRAPHY; IMMUNODEFICIENCY VIRUS, FELINE; POINT-OF-CARE SYSTEMS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; RETROVIRIDAE PROTEINS, ONCOGENIC; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; VACCINATION; VIRAL VACCINES;

EID: 84946923078     PISSN: 01479571     EISSN: 18781667     Source Type: Journal    
DOI: 10.1016/j.cimid.2015.07.004     Document Type: Article

References (37)

1. Pedersen N., Ho E., Brown M., Yamamoto J. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 1987, 235:790-793.
2. Gleich S.E., Krieger S., Hartmann K. Prevalence of feline immunodeficiency virus and feline leukaemia virus among client-owned cats and risk factors for infection in Germany. J. Feline Med. Surg. 2009, 11:985-992.
3. Levy J.K., Scott H.M., Lachtara J.L., Crawford P.C. Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity. J. Am. Vet. Med. Assoc. 2006, 228:371-376.
4. Ravi M., Wobeser G.A., Taylor S.M., Jackson M.L. Naturally acquired feline immunodeficiency virus (FIV) infection in cats from western Canada: prevalence, disease associations, and survival analysis. Can. Vet. J. 2010, 51:271-276.
5. Hosie M., Robertson C., Jarrett O. Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet. Rec. 1989, 125:293-297.
6. Norris J.M., Bell E.T., Hales L., Toribio J.-A.L.M.L., White J.D., Wigney D.I., Baral R.M., Malik R. Prevalence of feline immunodeficiency virus infection in domesticated and feral cats in eastern Australia. J. Feline Med. Surg. 2007, 9:300-308.
7. Jenkins K.S., Dittmer K.E., Marshall J.C., Tasker S. Prevalence and risk factor analysis of feline haemoplasma infection in New Zealand domestic cats using a real-time PCR assay. J. Feline Med. Surg. 2013, 15:1063-1069.
8. Nakamura Y., Nakamura Y., Ura A., Hirata M., Sakuma M., Sakata Y., Nishigaki K., Tsujimoto H., Setoguchi A., Endo Y. An updated nation-wide epidemiological survey of feline immunodeficiency virus (FIV) infection in Japan. J. Vet. Med. Sci. 2010, 72:1051-1056.
9. Kann R.K.C., Kyaw-Tanner M.T., Seddon J.M., Lehrbach P.R., Zwijnenberg R.J.G., Meers J. Molecular subtyping of feline immunodeficiency virus from domestic cats in Australia. Aust. Vet. J. 2006, 84:112-116.
10. Hayward J.J., Rodrigo A.G. Molecular epidemiology of feline immunodeficiency virus in the domestic cat (Felis catus). Vet. Immunol. Immunopathol. 2010, 134:68-74.
11. Hayward J.J., Taylor J., Rodrigo A.G. Phylogenetic analysis of feline immunodeficiency virus in feral and companion domestic cats of New Zealand. J. Virol. 2007, 81:2999-3004.
12. Yamamoto J.K., Pu R.Y., Sato E., Hohdatsu T. Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine. AIDS 2007, 21:547-563.
13. Iwata D., Holloway S.A. Molecular subtyping of feline immunodeficiency virus from cats in Melbourne. Aust. Vet. J. 2008, 86:385-389.
14. Sodora D.L., Shpaer E.G., Kitchell B.E., Dow S.W., Hoover E.A., Mullins J.I. Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus Type 1 evolutionary patterns. J. Virol. 1994, 68:2230-2238.
15. Duarte A., Marques M.I., Tavares L., Fevereiro M. Phylogenetic analysis of five Portuguese strains of FIV. Arch. Virol. 2002, 147:1061-1070.
16. Kusuhara H., Hohdatsu T., Okumura M., Sato K., Suzuki Y., Motokawa K., Gemma T., Watanabe R., Huang C.J., Arai S., Koyama H. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype BFIV infected cats. Vet. Microbiol. 2005, 108:155-165.
17. Huang C., Conlee D., Gill M., Chu H.-J. Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge. J. Feline Med. Surg. 2010, 12:451-457.
18. Hosie M.J., Beatty J.A. Vaccine protection against feline immunodeficiency virus: setting the challenge. Aust. Vet. J. 2007, 85:5-12.
19. Hartmann K., Griessmayr P., Schulz B., Greene C.E., Vidyashankar A.N., Jarrett O., Egberink H.F. Quality of different in-clinic test systems for feline immunodeficiency virus and feline leukaemia virus infection. J. Feline Med. Surg. 2007, 9:439-445.
20. Sand C., Englert T., Egberink H., Lutz H., Hartmann K. Evaluation of a new in-clinic test system to detect feline immunodeficiency virus and feline leukemia virus infection. Vet. Clin. Pathol. 2010, 39:210-214.
21. Uhl E.W., Heaton-Jones T.G., Pu R., Yamamoto J.K. FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review. Vet. Immunol. Immunopathol. 2002, 90:113-132.
22. Crawford P.C., Levy J.K. New challenges for the diagnosis of feline immunodeficiency virus infection. Vet. Clin. N. Am. Small Anim. Pract. 2007, 37:335-350.
23. Morton J.M., McCoy R.J., Kann R.K.C., Gardner I.A., Meers J. Validation of real-time polymerase chain reaction tests for diagnosing feline immunodeficiency virus infection in domestic cats using Bayesian latent class models. Prev. Vet. Med. 2012, 104:136-148.
24. Kusuhara H., Hohdatsu T., Seta T., Nemoto K., Motokawa K., Gemma T., Watanabe R., Huang C.J., Arai S., Koyama H. Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats. Vet. Microbiol. 2007, 120:217-225.
25. Levy J.K., Crawford P.C., Kusuhara H., Motokawa K., Gemma T., Watanabe R., Arai S., Bienzle D., Hohdatsu T. Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats. J. Vet. Intern. Med. 2008, 22:330-334.
26. Litster A., Lin J.-M., Nichols J., Weng H.-Y. Diagnostic utility of CD4%:CD8(low)% T-lymphocyte ratio to differentiate feline immunodeficiency virus (FIV)-infected from FIV-vaccinated cats. Vet. Microbiol. 2014, 170:197-205.
27. Westman M.E., Malik R., McDonagh P., Ward M.P., Hall E., Johnson J., Norris J.M. Prevalence of Feline Immunodeficiency Virus and Feline Leukaemia Virus Among Privately Owned and Shelter Cats in Australia (2011-2013) 2015, (In preparation).
28. Litster A., Leutenegger C., Estrada M., Nichols J., Hosie M., Beczkowski P. Diagnostic accuracy of a commercially available PCR test to detect feline immunodeficiency virus antigen. 2nd Biennial Symposium of ISCAID 2012.
29. Levy J.K., Crawford P.C., Slater M.R. Effect of vaccination against feline immunodeficiency virus on results of serologic testing in cats. J. Am. Vet. Med. Assoc. 2004, 225:1558-1561.
30. Pinches M.D.G., Diesel G., Helps C.R., Tasker S., Egan K., Gruffydd-Jones T.J. An update on FIV and FeLV test performance using a Bayesian statistical approach. Vet. Clin. Pathol. 2007, 36:141-147.
31. Lappin M.R. Detection of feline immunodeficiency virus antibodies in serum of vaccinated cats using a commercially available kit. J. Vet. Intern. Med. 2015, 86.
32. Levy J., Crawford C., Hartmann K., Hofmann-Lehmann R., Little S., Sundahl E., Thayer V. 2008 American Association of Feline Practitioners' feline retrovirus management guidelines. J. Feline Med. Surg. 2008, 10:300-316.
33. Coleman J.K., Pu R., Martin M.M., Noon-Song E.N., Zwijnenberg R., Yamamoto J.K. Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies. Vaccine 2014, 32:746-754.
34. http://www.idexx.com.au/pdf/en_au/smallanimal/education/realpcr-test-for-fiv.pdf.
35. https://www.idexx.com/files/small-animal-health/products-and-services/snap-products/snap-fiv-felv-combo/snap-combo-test-accuracy.pdf.
36. https://www.idexx.com/resource-library/smallanimal/snap-combo-package-insert-en.pdf.
37. http://www.gribblesvets.com.au/index.php/download_file/view/90/142/.